Title: Additional mRNA Covid-19 Vaccines for Moderately to Severely Immunocompromised People
Tuesday, August 17th, 2:00-3:00 PM ET.
During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage
a few hours after the live event ends.
The slide set will be available under "Call Materials" on the COCA Call webpage
REGISTRATION IS NOT REQUIRED.
A few minutes before the webinar starts, please click on the Zoom link below to join:
Title: COVID-19 Vaccine Confidence Bootcamp on the Rapid Community Assessment (RCA)
Monday, August 23, 2021, 2:00-4:00 PM ET.
You are cordially invited to attend a COVID-19 Vaccine Confidence Bootcamp on the Rapid Community Assessment (RCA)
hosted by the Centers for Disease Control (CDC) on Monday, August 23, 2021
from 2:00-4:00 PM ET.
This bootcamp will provide guidance on how to conduct a rapid community assessment
to identify perceptions of and barriers to COVID-19 vaccine confidence and demand in communities of focus and how to address those barriers with recommended strategies.
This 2-hour webinar will provide:
An overview of the Rapid Community Assessment (RCA);
- Recommended timeline for conducting a RCA;
- Outcomes from previous RCAs;
- Question & Answer session
- A facilitated breakout session to begin planning RCAs in specific communities
Pre-registration is required. This bootcamp is provided via Zoom. The meeting access link will be provided after pre-registration. Seats are limited to 200 participants.
Registration closes on Friday, August 20, 2021 @ 8PM ET.
Title: Partisan Divides and How to Improve Vaccination Rates
September 1, 2021, 3:00pm ET to 4:00pm ET
The Indiana Immunization Coalition
is offering a webinar titled How Political Partisanship Impacts Vaccination
on September 1 at 3:00 p.m. (ET). This webinar featuresBrian Castrucci, DrPH, MA, President and chief executive officer of the de Beaumont Foundation. He will discuss how partisan divides may be affecting herd immunity, and how to achieve the best public health outcomes.
Brian is an award-winning epidemiologist with ten years of experience working in state and local health departments. Brian brings a unique perspective to the philanthropic sector that allows him to implement visionary and practical initiatives and partnerships and bring together research and practice to improve public health.
Brian has published more than seventy articles in the areas of public health systems and services research, maternal and child health, health promotion, and chronic disease prevention. His recent work has focused on the public health needs of large cities, the need for better data systems, and public health system improvements.
CME, CNE, and Pharmacy Continuing Education will be offered.
On August 12, 2021 FDA modified the Emergency Use Authorizations (EUAs) for Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine to allow for administration of an additional dose (i.e., a third dose) of an mRNA COVID-19 vaccine after an initial 2-dose primary mRNA COVID-19 vaccine series for certain immunocompromised people (i.e., people who have undergone solid organ transplantation or have been diagnosed with conditions that are considered to have an equivalent level of immunocompromise). The age groups authorized to receive the additional dose are unchanged from those authorized to receive the primary vaccination series:
- Pfizer-BioNTech: aged ≥12 years
- Moderna: aged ≥18 years
On August 13, 2021, ACIP met and reviewed the data for use of an additional dose of mRNA COVID-19 vaccine for immunocompromised people within the Evidence to Recommendation Framework. ACIP made an interim recommendation for use of an additional dose of Pfizer-BioNTech COVID-19 vaccine (for persons aged ≥12 years) or Moderna COVID-19 vaccine (for persons aged ≥18 years) after an initial 2-dose primary mRNA COVID-19 vaccine series for moderately to severely immunocompromised people.
Healthcare professionals and public health officials should consider the following for use of an additional mRNA COVID-19 vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series for moderately to severely immunocompromised people:
- The currently FDA-authorized COVID-19 vaccines are not live vaccines and therefore can be safely administered to immunocompromised people.
- Studies indicate some immunocompromised people have a reduced immune response following a primary COVID-19 vaccine series compared to vaccine recipients who are not immunocompromised.
- Studies have further demonstrated that including an additional mRNA COVID-19 vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series in some immunocompromised populations may enhance immune response.
- The clinical benefit of an additional mRNA vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series for immunocompromised people is not precisely known. However, for people with moderate to severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, the potential to increase immune response coupled with an acceptable safety profile, support the recommendation for an additional mRNA vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series.
- The additional dose should be administered at least 28 days after the completion of the initial mRNA COVID-19 vaccine series.
The clinical considerations for use of an additional dose of an mRNA COVID-19 vaccine apply only to people who are moderately or severely immunocompromised.
For access to the updated Clinical Considerations, please visit here.
Moderna EUA & Pfizer Emergency Use Authorizations (EUAs) Updated
The updated EUAs can be found at the links below.
EUA Pfizer fact sheet providers:
EUA Pfizer fact sheet recipient:
EUA Moderna fact sheet providers:
EUA Moderna fact sheet recipients:
Voices For Vaccines
Voices for Vaccines (VFV)
is a parent-driven organization supported by scientists, doctors, and public health officials that provides parents clear, science-based information about vaccines and vaccine-preventable disease, as well as an opportunity to join the national discussion about the importance of on-time vaccination. Each week VFV sends a newsletter highlighting current misinformation about vaccines (see "the claim" below) and offers accurate information countering the misinformation ("the facts").
Below, please find an example of what this newsletter offers:
Concerns about changes in menstruation after vaccination have some wondering if
the two are connected and what this could mean.
The tough part about studying
the possibility that COVID vaccines are changing some people's periods is the difficulty teasing out minor side effects in trials and studies. Trials are really good at discovering severe side effects but not as good about finding relatively minor changes. Such small effects are easily overlooked and could be caused by innumerable factors.
The good news is that even if there were a causal relationship between being vaccinated and experiencing menstrual cycle irregularities, those changes seem to be short-lived
, with no lasting impact.
If you are interested in receiving this weekly email, you can click here
to sign up. This may be helpful knowledge as you navigate conversations about vaccines with your patients.
Trust the Facts. Get the Vax Resources
Find below these fantastic resources promoting Covid-19 vaccination, including a cadre of animated videos in 12 languages!
Trust the Facts. Get the Fax.
In addition, you can find posters and fliers in the link below.
MA Health Promotion Clearinghouse
CDC Health Alert Network sends notice of the urgent need to increase COVID-19 vaccination coverage
On July 27, the CDC Health Alert Network (HAN) issued an advisory
to notify public health practitioners and clinicians about the urgent need to increase COVID-19 vaccination coverage across the United States, particularly in regions where current coverage is low. Increased coverage will help to prevent surges in new infections that could increase COVID-19 related morbidity and mortality, overwhelm healthcare capacity, and widen existing COVID-19-related health disparities. In addition to vaccination, in areas with substantial and high transmission, CDC recommends that fully vaccinated individuals wear a mask in public indoor settings to help prevent the spread of Delta and protect others.
To sign up for Health Alert Network email updates, go to the CDC News & Updates web page
, enter your email address, and click ‘Register.’
National Immunization Awareness Month
August is National Immunization Awareness Month (NIAM). Join CDC and other partners in educating and bringing awareness to the importance of getting caught up on healthcare appointments and routine vaccinations. Due to the Covid-19 pandemic, some families and individuals missed their routine checkups and vaccinations. With children going back to school and adults going back to the workplace, it is now more important than ever for everyone to get back on track with routine vaccinations.
Resources are available to help you encourage routinely recommended vaccines for a variety of audiences.
In addition, for those who are eligible, resources to aid conversations and inform individuals about the importance of COVID-19 vaccination are available.
Covid-19 Delta Variant Talking Points and Infographics
Last week, the CDC released its Delta Variant update. Please see the announcement and attachments for infographics and talking points to assist your communication efforts!
CDC Partner Packet - Delta Variant
Delta Variant: Should I Be Concerned?
Delta Variant: Do I Need To Wear A Mask?
Delta Variant: Are Vaccines Effective?
Delta Variant: What Should Communities Do?
Delta Variant: What Should Schools Do?
VEC Animation: How the mRNA Vaccine Works
Find here the latest resource from VEC, an animation that shows how the mRNA vaccine works!
The animation is available on the Vaccine Makers Project (VMP) YouTube Channel. It can also be accessed from the VEC homepage (vaccine.chop.edu
) and on COVIDVaccineAnswers.org
MDPH COVID-19 Vaccine Website for Providers
The Massachusetts Department of Public Health has updated its COVID-19 Vaccine website
for providers. Here you will find information about prioritization, storage, handling, and other relevant information related to vaccination efforts. You also will find:
- Detailed guidance for healthcare providers and organizations
- Answers to frequently asked questions by providers
- Links to CDC and FDA resources
MDPH recommends checking the website frequently in order to stay up to date with the latest information.
Link to most recent Immunization MMWRs
to view all recent MMWRs!